Legal
Key facts
Robbins LLP says a securities class action has been filed on behalf of investors in ARS…
Key facts
The action concerns ARS Pharmaceuticals Inc. securities purchased or otherwise acquired between March 9, 2026 and…
Key facts
ARS Pharmaceuticals Inc. trades on NASDAQ under ticker SPRY
Atlas Watchline
Robbins LLP says a securities class action targets ARS Pharmaceuticals over claims it misled investors about…